Cissus quadrangularis augments IGF system components in human osteoblast like SaOS-2 cells

Growth Hormone and IGF Research

Volumn 21, Issue 6, 2011, Pages 343-348

  Muthusami, Sridhar ^a   Ramachandran, Ilangovan ^a   Krishnamoorthy, Senthilkumar ^a   Govindan, Ramajayam ^a   Narasimhan, Srinivasan ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

C. quadrangularis; IGF I; IGF II; IGF IR; IGFBP 3; SaOS 2 cells

Indexed keywords

CISSUS QUADRANGULARIS EXTRACT; MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; IN VITRO STUDY; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 3 GENE; INSULIN LIKE GROWTH FACTOR I GENE; INSULIN LIKE GROWTH FACTOR I RECEPTOR GENE; INSULIN LIKE GROWTH FACTOR II GENE; MOLECULAR DYNAMICS; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CISSUS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOBLASTS; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; RNA, MESSENGER;

EID: 80055083169     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2011.09.002     Document Type: Article

References (57)

1. Arjmandi B.H., Khalil D.A., Lucas E.A., et al. Dried plums improve indices of bone formation in postmenopausal women. J. Womens Health Gend. Based Med. 2002, 11:61-68.
2. Baumrucker C.R., Hadsell D.L., Blum J.W. Effects of dietary insulin-like growth factor I on growth and insulin-like growth factor receptors in neonatal calf intestine. J. Anim. Sci. 1994, 72:428-433.
3. Beretz A., Anton R., Stoclet J.C. Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase. Experientia 1978, 34:1054-1055.
4. Boonen S., Mohan S., Dequeker J., Aerssens J., Bouillon R., Baylink D.J. Deficit of the serum stimulatory components of insulin-like growth factor system in patients with osteoporosis and femoral neck fracture. J. Bone Miner. Res. 1996, 11:328.
5. Canalis E., Pash J., Varghese S. Skeletal growth factors. Crit. Rev. Eukaryot. Gene Expr. 1993, 3:155-166.
6. Conover C.A. Insulin-like growth factor-binding proteins and bone metabolism. Am. J. Physiol. Endocrinol. Metab. 2008, 294:10-14.
7. Eingartner C., Coerper S., Fritz J., Gaissmaier C., Koveker G., Weise K. Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis. Int. Orthop. 1999, 23:253-259.
8. Einhorn T.A., Lee C.A. Bone regeneration: new findings and potential clinical applications. J. Am. Acad. Orthop. Surg. 2001, 9:157-165.
9. Ferrell J.E., Chang Sing P.D., Loew G., King R., Mansour J.M., Mansour T.E. Structure/activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices. Mol. Pharmacol. 1979, 16:556-568.
10. Fitzsimmons R.J., Strong D.D., Mohan S., Baylink D.J. Low-amplitude, low-frequency electric field-stimulated bone cell proliferation may in part be mediated by increased IGF-II release. J. Cell. Physiol. 1992, 150:84-89.
11. Fowlkes J.L., Thrailkill K.M., Liu L., et al. Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model. J. Bone Miner. Res. 2006, 21:1359-1366.
12. Frigo D.E., Duong B.N., Melnik L.I., et al. Flavonoid phytochemicals regulate activator protein-1 signal transduction pathways in endometrial and kidney stable cell lines. J. Nutr. 2002, 132:1848-1853.
13. Gann P.H., Kazer R., Chatterton R., et al. Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int. J. Cancer 2005, 116:297-303.
14. Garnero P., Sornay-Rendu E., Delmas P.D. Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 2000, 355:898-899.
15. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb W., Ferrara N. VEGF couples hypertropic cartilage remodeling, and angiogenesis during endochondral bone formation. Nat. Med. 1999, 5:623-628.
16. Ghiron L.J., Thompson J.L., Holloway L., et al. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J. Bone Miner. Res. 1995, 10:1844-1852.
17. Goad D.L., Rubin J., Wang H., Tashjian A.H., Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulinlike growth factor I. Endocrinology 1996, 137:2262-2268.
18. Goldring M.B., Goldring S.R. Skeletal tissue response to cytokines. Clin. Orthop. Relat. Res. 1990, 258:245-278.
19. Gutendorf B., Westendorf J. Comparison of an array of in vitro assay for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 2001, 166:79-89.
20. Hall L.J., Kajimoto Y., Bichell D., et al. Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol. 1992, 11:301-313.
21. Hayden J.M., Mohan S., Baylink D.J. The insulin-like growth factor system and the coupling of formation to resorption. Bone 1995, 17:93-98.
22. Honda Y., Fitzsimmons R.J., Baylink D.J., Mohan S. Effects of extracellular calcium on insulin-like growth factor II in human bone cells. J. Bone Miner. Res. 1995, 10:1660-1665.
23. -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995, 136:2671-2677.
24. Jiang J., Lichtler A.C., Gronowicz G.A., et al. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 2006, 39:494-504.
25. Kappel C.C., Velez-Yanguas M.C., Hirschfeld S., Helman L.J. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res. 1994, 54:2803-2807.
26. Kim J., Um S.J., Woo J., et al. Comparative effect of seeds of Rhynchosia volubilis and soybean on MG-63 human osteoblastic cell proliferation and estrogenicity. Life Sci. 2005, 78:30-40.
27. Kim J.Y., Kim E.H., Park S.S., Lim J.H., Kwon T.K., Choi K.S. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. J. Cell. Biochem. 2008, 105:1386-1398.
28. Knutsen R., Honda Y., Strong D.D., Sampath T.K., Baylink D.J., Mohan S. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells. Endocrinology 1995, 136:857-865.
29. Koch H., Jadlowiec J.A., Campbell P.G. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells. Stem Cells Dev. 2005, 14:621-631.
30. Lee Y.S., Choi C.W., Kim J.J., Ganapathi A., Udayakumar R., Kim S.C. Determination of mineral content in methanolic safflower (Carthamus tinctorius L.) seed extract and its effect on osteoblast markers. Int. J. Mol. Sci. 2009, 10:292-305.
31. Libanati C., Rajaram S., Baylink D.J., Mohan S. In a longitudinal prospective study, glucocorticoid (GC) therapy causes a marked reduction in bone formation markers and stimulatory insulin-like growth factor (IGF) system components. J. Bone Miner. Res. 1996, 11:S150.
32. Maeno T., Tanaka T., Sando Y., et al. Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am. J. Respir. Cell Mol. Biol. 2002, 26:246-253.
33. McCarthy T.L., Centrella M., Canalis E. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 1989, 124:301-309.
34. Mochizuki S., Yoshida S., Yamanaka Y., Matsuo H., Maruo T. Effects of estriol on proliferative activity and expression of insulin-like growth factor-I (IGF-I) and IGF-I receptor mRNA in cultured human osteoblast-like osteosarcoma cells. Gynecol. Endocrinol. 2005, 20:6-12.
35. Mohan S., Baylink D.J. Bone growth factors. Clin. Orthop. Relat. Res. 1991, 263:30-48.
36. Mohan S., Strong D.D., Lempert U.G., Tremollieres F., Wergedal J.E., Baylink D.J. Studies on regulation of insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-4 production in human bone cells. Acta Endocrinol. 1992, 127:555-564.
37. Mukherjee A., Rotwein P. Akt promotes BMP2-mediated osteoblast differentiation and bone development. J. Cell Sci. 2009, 122:716-726.
38. Muthusami S., Senthilkumar K., Vignesh C., Ilangovan R., Stanley J., Selvamurugan N., Srinivasan N. Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 Cells. J. Cell. Biochem. 2011, 112:1035-1045.
39. Nakasaki M., Yoshioka K., Miyamoto Y., Sasaki T., Yoshikawa H., Itoh K. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone 2008, 43:869-879.
40. Okazaki K., Jingushi S., Ikenoue T., Urabe K., Sakai H., Iwamoto Y. Expression of parathyroid hormone-related peptide and insulin-like growth factor I during rat fracture healing. J. Orthop. Res. 2003, 21:511-520.
41. Olney R.C., Wilson D.M., Mohtai M., Fielder P.J., Smith R.L. Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J. Endocrinol. 1995, 146:279-286.
42. Raschke M., Wildemann B., Inden P., et al. Insulin-like growth factor-1 and transforming growth factor-beta1 accelerates osteotomy healing using polylactide-coated implants as a delivery system: a biomechanical and histological study in minipigs. Bone 2002, 30:144-151.
43. Rosen C.J., Donahue L.R., Hunter S.J. Insulin-like growth factors and bone: the osteoporosis connection. Proc. Soc. Exp. Biol. Med. 1994, 206:83-102.
44. Schmidmaier G., Wildemann B., Bail H., Lucke M., Fuchs T., Stemberger A. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D, L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. Bone 2001, 28:341-350.
45. Singh G., Rawat P., Maurya R. Constituents of Cissus quadrangularis. Nat. Prod. Res. 2007, 21:522-528.
46. Solakidi S., Psarra A.M., Sekeris C.E. Differential distribution of glucocorticoid and estrogen receptor isoforms: localization of ERbeta and ERalpha in nucleoli and ERalpha and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. J. Musculoskelet. Neuronal. Interact. 2007, 7:240-245.
47. Son Y.O., Kook S.H., Choi K.C., et al. Quercetin accelerates TNF-alpha-induced apoptosis of MC3T3-E1 osteoblastic cells through caspase-dependent and JNK-mediated pathways. Eur. J. Pharmacol. 2008, 579:26-33.
48. Spelsberg T.C., Subramaniam M., Riggs B.L., Khosla S. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol. Endocrinol. 1999, 13:819-828.
49. Tremollieres F., Strong D., Bayllink D., Mohan S. Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-II production. Acta Endocrinol. 1992, 126:329-337.
50. Udupa K.N., Prasad G. Further studies on the effect of C. quadrangularis in accelerating fracture healing. Ind. J. Med. Res. 1964, 52:26.
51. Umayahara Y., Ji C., Centrella M., Rotwein P., McCarthy T.L. CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J. Biol. Chem. 1997, 272:31793-31800.
52. Umayahara Y., Kawamori R., Watada H. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 1994, 269:16433-16442.
53. Wang Y., Nishida S., Boudignon B.M., et al. IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J. Bone Miner. Res. 2007, 22:1329-1337.
54. Weinzimer S., Cohen P. Biological significance of the IGFBPs. Growth and Lactogenic hormones 2002, Volume.2. Elsevier sciences. L. Matera, R. Rappaporrt (Eds.).
55. Wu J.B., Fong Y.C., Tsai H.Y., Chen Y.F., Tsuzuki M., Tang C.H. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur. J. Pharmacol. 2008, 588:333-341.
56. Yeh L.C., Adamo M.L., Olson M.S., Lee J.C. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology 1997, 138:4181-4190.
57. Bu S.Y., Hunt T.S., Smith B.J. Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up regulation of Runx2, Osterix and IGF-1. J. Nutr. Biochem. 2009, 20:35-44.